Target validation and drug discovery efforts on exoribonuclease XRN1

被引：0
|
作者：
Lynes, Maureen M.
Lockbaum, Gordon J.
Sparling, Brian A.
Shen, Sophie A.
Nayak, Sunaina P.
Knockenhauer, Kevin
Grigoriu, Simina
Buker, Shane M.
Duncan, Kenneth W.
Copeland, Robert A.
Blakemore, Stephen J.
Silver, Serena J.
Boriack-Sjodin, P. Ann
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2024年 / 23卷 / 11期
关键词：
D O I：
10.1158/1538-8514.RNADRIVERS24-PR006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR006
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Crystal structure of the 5′ → 3′ exoribonuclease Xrn1
    Chang, Jeong Ho
    Tong, Liang
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2011, 67 : C690 - C690
  • [2] Structural and biochemical studies of the 5′→3′ exoribonuclease Xrn1
    Chang, Jeong Ho
    Xiang, Song
    Xiang, Kehui
    Manley, James L.
    Tong, Liang
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2011, 18 (03) : 270 - U49
  • [3] Structural and biochemical studies of the 5′→3′ exoribonuclease Xrn1
    Jeong Ho Chang
    Song Xiang
    Kehui Xiang
    James L Manley
    Liang Tong
    Nature Structural & Molecular Biology, 2011, 18 : 270 - 276
  • [4] The exoribonuclease Xrn1 is a post-transcriptional negative regulator of autophagy
    Delorme-Axford, Elizabeth
    Abernathy, Emma
    Lennemann, Nicholas J.
    Bernard, Amelie
    Ariosa, Aileen
    Coyne, Carolyn B.
    Kirkegaard, Karla
    Klionsky, Daniel J.
    AUTOPHAGY, 2018, 14 (05) : 898 - 912
  • [5] Identification of phlebovirus and arenavirus RNA sequences that stall and repress the exoribonuclease XRN1
    Charley, Phillida A.
    Wilusz, Carol J.
    Wilusz, Jeffrey
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (01) : 285 - 295
  • [6] Unravelling the impact of the 5′-3′ exoribonuclease XRN1 in the HIV-1 replication cycle
    Marin-Rojas, J.
    Gaete-Argel, A.
    Velasquez, F.
    Chnaiderman, J.
    SotoRifo, R.
    Valiente-Echeverria, F.
    FEBS OPEN BIO, 2022, 12 : 156 - 157
  • [7] Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3’,5’-bisphosphate as a potent enzyme inhibitor
    Gordon J. Lockbaum
    Maureen M. Lynes
    Sophie A. Shen
    Julie Liu
    Nicholas Holt
    Sunaina P. Nayak
    Kevin E. Knockenhauer
    Shihua Yao
    E. Allen Sickmier
    Anugraha Raman
    Jie Wu
    April Case
    Livia Shehaj
    Shane M. Buker
    Simina Grigoriu
    Scott Ribich
    Stephen J. Blakemore
    Brian A. Sparling
    Kenneth W. Duncan
    Robert A. Copeland
    Serena J. Silver
    P. Ann Boriack-Sjodin
    Communications Biology, 8 (1)
  • [8] The 5'? 3' exoribonuclease XRN1/Pacman and its functions in cellular processes and development
    Jones, Christopher Iain
    Zabolotskaya, Maria Vasilyevna
    Newbury, Sarah Faith
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2012, 3 (04) : 455 - 468
  • [9] The Yeast DNA Damage Checkpoint Kinase Rad53 Targets the Exoribonuclease, Xrn1
    Lao, Jessica P.
    Ulrich, Katie M.
    Johnson, Jeffrey R.
    Newton, Billy W.
    Vashisht, Ajay A.
    Wohlschlegel, James A.
    Krogan, Nevan J.
    Toczyski, David P.
    G3-GENES GENOMES GENETICS, 2018, 8 (12): : 3931 - 3944
  • [10] Exoribonuclease XRN1 is a therapeutic vulnerability in tumors with intrinsically elevated type I interferon signaling
    Lynes, Maureen M.
    Shen, Sophie A.
    Nayak, Sunaina P.
    Sparling, Brian A.
    Ribich, Scott
    Blakemore, Stephen J.
    Silver, Serena J.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
12345